Intraoperative detection of occult colon cancer micrometastases using 125I-radiolabeled monoclonal antibody CC49

Cancer

Volumn 77, Issue 4, 1996, Pages 613-620

  Cote, Richard J ^a   Houchens, David P ^b   Hitchcock, Charles L ^c   Saad, Anu D ^d   Nines, Ronald G ^b   Greenson, Joel K ^e   Schneebaum, Schlomo ^c   Arnold, Mark W ^c   Martin Jr , Edward W ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Neoprobe Corporation   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d IMPATH Inc   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; IODINE 125; MONOCLONAL ANTIBODY CC49; TUMOR ANTIGEN;

ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METASTASIS; OCCULT CANCER; PRIORITY JOURNAL; RADIOSURGERY; RECURRENT CANCER;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CHI-SQUARE DISTRIBUTION; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; GAMMA CAMERAS; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; KERATINS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; POTASSIUM IODIDE; PROBABILITY; RADIOIMMUNODETECTION; RECURRENCE; REPRODUCIBILITY OF RESULTS;

EID: 0030062915     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960215)77:4<613::AID-CNCR5>3.0.CO;2-H     Document Type: Article

References (26)

1. Goldenbcrg DM, Deland FH, Kim EE, Bennett S, Primes FJ, van Nagell JR, Estes N, DeSimone P, Rayburn P. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photo scanning. N Engl J Med 1978;298:1384-8.
2. Mach JP, Carrel S, Forni M, Ritzchard J, Donnath A, Alberto P. Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma. N Engl J Med 1980;303:5-10.
3. Lange MK, Martin EW Jr. Monoclonal antibodies in imaging and therapy of colorectal cancer. World J Surg 1991;15:617-22.
4. Halpern ST. An overview of radioimmunoimaging. In: Maquire, RT, Van Nostrand D, editors. Diagnosis of colorectal and ovarian carcinoma. New York: Marcel Dekker, Inc., 1992:1-22.
5. Martin DT, Aitken D, Thurston MO, Haagenson D, Hinkle G, Olsen J, et al. Successful experimental use of a self-contained gamma-detecting device. Curr Surg 1984;41:193-4.
6. Hinkle GH, Mojzisik CM, Loesch JA, Hill TL, Thurston MO, Sampsel J, et al. The evolution of the radioimmunoguided surgery system: an innovative technique for the intraoperative detection of tumor. Antibod, Immunocon and Radiopharm 1991;4:339-58.
7. Arnold MW, Schneebaum S, Berens A, Mojzisik C, Hinkle G, Martin EW Jr. Radioimmunoguided surgery challenges traditional decision making in patients with primary colorectal cancer. Surgery 1992;112:624-30.
8. Arnold MW, Schneebaum S, Berens A, Petty L, Mojzisik C, Hinkle G, et al. Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, a second-generation monoclonal antibody. Ann Surg 1992;216:627-32.
9. Trojani M, de Mascarel I, Bonichon F, Condre JM, Delsol F. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 1987;55:303-6.
10. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990;335:1565-8.
11. Sedmak DD, Meineke TA, Knechtges DS, Anderson J. Prognostic significance of cytokeratin-positive breast cancer metastases. Mod Pathol 1989;2:516-20.
12. Molinolo A, Simpson JF, Thor A, Schlom J, et al. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissues. Cancer Res 1990;50:1291-8.
13. Cote RJ, Cordon-Cardo C, Reuter VE, Rosen PP. Immunopathology of adrenal and renal cortical tumors: coordinated change in antigen expression is associated with neoplastic conversion in the adrenal cortex. Am J Pathol 1990; 136:1077-84.
14. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
15. Sampsel JW, Lange MK, Ignaszewski J, Hinkle G, Sandhu AK, Sandhu G, et al. Autoradiographic (ARG) localization of various radiolabeled monoclonal antibodies (MoAbs) in tissue sections of CX-1 colon tumor xenografts. Antibod, Immuno, and Radiopharm 1991;4:453-458.
16. Cohen AM, Martin EW Jr., Lavery I, Daly J, Sardi A, Aitken D, et al. Radioimmunoguided surgery using iodine 125 B72.3 in patients with colorectal cancer. Arch Surg 1991;126:349-52.
17. Schneebaum S, Arnold MW, Houchens D, Greenson JK, Cote RJ, Hitchcock CL, et al. The importance of intraoperative periportal lymph node metastasis identification. Cancer 1995;75:2809-17.
18. Arnold MW, Young DC, Hitchcock CL, Schneebaum S, Martin EW Jr. Radioimmunoguided surgery in primary colorectal carcinoma: a bioprognostic indicator independent of traditional staging. Am J Surg 1995;70:315-318.
19. Martin EW Jr., Carey LC. Second look surgery for colorectal cancer: the second time around. Ann Surg 1991;214:321-327.
20. Cote R, Chaiwun B, Qu J, Taylor C, Peterson H, Gelber R, et al. Prognostic importance of occult lymph node metastases in patients with breast cancer. Proc Am Ass Cancer Res 1992;33:202.
21. Byme J, Waldron R, McAvinchey D, Dervan P. The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastases. Eur J Surg Oncol 1987;13:409-11.
22. Cochran AJ, Wen D-R, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological Stage I malignant melanoma. Am J Surg Pathol 1988;12:612-618.
23. Chen Z-L, Perez S, Holmes EC, Wang H-J, Coulson WF, Wen D-Ren, et al. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 1993;85:493-8.
24. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW. Identification of occult micrometastases in periocolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer 1994;73:563-9.
25. Deguchi T, Doi T, Ehara H, Ito SI, Takahashi Y, Nishin, et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase polymerase chain reaction. Cancer Res 1993;53:5350-4.
26. Hayashi N, Arakawa H, Nagase H, Yanagisawa A, Katoy, Ohta H, et al. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathologic method. Cancer Res 1994;54:3853-6.